Live Breaking News & Updates on Osmotica pharmaceutical corp

Stay informed with the latest breaking news from Osmotica pharmaceutical corp on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Osmotica pharmaceutical corp and stay connected to the pulse of your community

CSI Appoints Ken Gayron as Chief Financial Officer

CSI Appoints Ken Gayron as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

David-culbertson , Ken-gayron , Osmotica-pharmaceutical-corp , Sierra-wireless , Nuance-communications , Computer-services-inc , Sensus-inc , Chief-financial , Business-wire , Numerex-corporation-a , Computer-services ,

Financial software provider CSI names new CFO

Financial software provider CSI names new CFO
lanereport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lanereport.com Daily Mail and Mail on Sunday newspapers.

David-culbertson , Ken-gayron , Ken-grayon , Numerex-corporation , Osmotica-pharmaceutical-corp , Sierra-wireless , Sensus-inc , Nuance-communications ,

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO
Invectys, Inc.May 4, 2021 GMT
Houston, TX, USA, May 04, 2021 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products for cancer patients, today announced the appointment of Praveen Tyle, PhD, as President & CEO and election to its Board of Directors. Dr. Tyle brings over 35 years of experience in both large and small pharma and biotech companies, most recently serving as Executive V.P. for Research and Development of the public company, Lexicon Pharmaceuticals, Inc. Earlier, Dr. Tyle served as the Corporate Senior Vice President and Chief Scientific Officer of Bausch and Lomb and then as Senior Vice President and Global Head of Business Development and R&D at Novartis OTC. Subsequently, Dr. Tyle joined Osmotica Pharmaceutical Corp. serving as President and CEO where he led the successful merger of the Company into Avista Partners in 2016.

Houston , Texas , United-states , Paris , France-general , France , Pasteur-institute , Shannon-fairbanks , Cary-mcnair , Virginie-leplat , Research-initiative-of-texas , Fairbanks-investment-fund-holdings